Diabetics Only? Who Can and Can’t Use Mounjaro in Dubai UAE

In Dubai, there is a common misconception that Mounjaro (tirzepatide) is only intended for individuals with diabetes, primarily due to its initial approval for Type 2 Diabetes. However, medical guidelines in Dubai, like those globally, have expanded the use of Mounjaro to include chronic weight management for certain individuals.

Understanding who can and cannot use Mounjaro in Dubai is essential, based on UAE guidelines:

Who Is Eligible for Mounjaro in Dubai? A licensed healthcare provider in Dubai may consider prescribing Mounjaro to adults (typically 18 years and older) who meet specific medical criteria and are willing to make lifestyle changes, including diet and exercise.

Adults with Type 2 Diabetes Mellitus: This remains a primary indication for Mounjaro. It is prescribed as an additional treatment to diet and exercise to help improve blood sugar control in adults with Type 2 Diabetes. By acting on GLP-1 and GIP receptors, Mounjaro can stimulate insulin release, reduce glucose production by the liver, slow gastric emptying, reduce appetite, and aid in weight loss, which is beneficial for many overweight or obese individuals with diabetes.

Adults for Chronic Weight Management: Contrary to popular belief, Mounjaro is also approved for chronic weight management in adults who are obese (BMI ≥ 30 kg/m²) or overweight (BMI ≥ 27 kg/m²) with at least one weight-related comorbidity, such as hypertension, dyslipidemia, obstructive sleep apnea, or established cardiovascular disease. When used as part of a comprehensive weight management program that includes a reduced-calorie diet and increased physical activity, Mounjaro can lead to significant weight loss and improvements in associated health conditions.

Before prescribing Mounjaro, a reputable healthcare provider in Dubai will conduct a thorough assessment, including a detailed medical history, physical examination, relevant blood tests, and a discussion about lifestyle habits and commitment to change.

Who Should Avoid Mounjaro in Dubai? Certain conditions preclude individuals from using Mounjaro in Dubai to prevent serious adverse effects:

Absolute Contraindications: Individuals with a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not take Mounjaro due to the increased risk of thyroid C-cell tumors. Severe hypersensitivity to Mounjaro or its components is also a contraindication.

Not Indicated or Not Studied: Mounjaro is not indicated for individuals with Type 1 Diabetes, children and adolescents under 18 years of age, those with a healthy BMI, or individuals seeking minor weight loss for cosmetic purposes.

Conditions Requiring Caution: Pregnant or breastfeeding women, individuals with a history of pancreatitis, severe gastrointestinal disease, severe kidney or liver impairment, or those using certain medications should approach Mounjaro with caution or may not be eligible for its use.

In conclusion, Mounjaro is a valuable tool for managing Type 2 Diabetes and chronic weight conditions in Dubai. However, its use is strictly regulated to ensure patient safety and adherence to medical guidelines. Individuals seeking Mounjaro should consult a licensed healthcare provider for a thorough evaluation and appropriate guidance. Obtaining Mounjaro from unauthorized sources or self-prescribing is not recommended and can have serious health and legal implications in the UAE.